Shaken bioprocesses rely heavily on the oxygen transfer rate (OTR) as an indirect measure of the oxygen uptake rate (OUR) to infer a cultivation's metabolic activity. However, accurately capturing ...

Alamance Community College (ACC) received a $474,878 grant from the National Science Foundation's Advanced Technological Education program to launch BioQuest, a project that will train students for ...

The North Carolina Biotechnology Center awarded 128 grants and loans totaling $7,404,019 to universities, life sciences ...

Merakris Therapeutics, a clinical-stage Research Triangle Park regenerative biologic medicines company, has received a $2.2 ...

Vogenx Inc. celebrated its Nasdaq debut with an Opening Bell ceremony in August after pricing its IPO at $13 per share, at ...

This event is a great opportunity to connect with the NC life sciences community, explore the latest advancements in protein analysis, exchange best practices, and discover the latest applications and ...

This insightful discussion around water sustainability in biopharma will feature four experts who focus on important steps in the water lifecycle: initial plant design facility ...

A pharmaceutical development startup born from local cancer research will receive a grant to provide a boost for its next phase of growth from the Greater Winston-Salem Inc.’s BioNest Fund. Deep Creek ...

TruLab, a provider of technology for overseeing drug clinical trials, has relocated to new offices in Research Triangle Park (RTP) to support its rapid growth and development. The company has signed a ...

Tune Therapeutics, an epigenome-editing company with origins at Duke University, has raised over $175 million in financing to advance a potential treatment for chronic hepatitis B and other diseases.

North Carolina’s gene and cell therapy magnet has attracted an investment from one of the state’s original biomanufacturers Biogen. The top-25 global pharmaceutical company, based in Cambridge, Mass., ...